Amneal has announced the
creation of Amneal Biosciences,
a wholly-owned subsidiary of
Amneal Pharmaceuticals to focus
exclusively on the commercialisation
of high-barrier-to-entry generic
and specialty pharmaceuticals
such as injectables, oncologics and
biosimilars to healthcare providers
globally.
Amneal co-ceo and chairman
Chirag Patel said, “Amneal has
a robust pipeline of both smallmolecule
injectable generics as well
as biosimilars, and we expect to
bring the first of these to market in
early 2016.
“Our experienced Amneal
Biosciences team provides the high
degree of expertise these specialty
products require.”
Heading Amneal Biosciences as
president is pharmacy veteran
Charles Lucarelli, MS, RPh. The above article was sent to subscribers in Pharmacy Daily's issue from 27 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Aug 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.